Study Design of a Phase 3, Open-Label Trial of the Safety and Efficacy of Recombinant Factor VIII Fc Fusion Protein for the Prevention and Treatment of Bleeding Episodes in Previously Untreated Patients With Severe Hemophilia A

Amy Shapiro, Guy Young, Steven Pipe, Johannes Oldenburg, Geoffrey Allen